ACTA1 and type 2 diabetes mellitus: While a previous study reported increased α-SMA-immunoreactive (α-SMA-ir) vessels in the hypothalamus of T2DM individuals [78], we found no significant differences in α-SMA-ir area across control, T1DM, and T2DM groups at different Braak stages (Figs. 5f–h).